trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Rapid admission to hospital following a stroke is vital for ensuring patients have timely access to treatments such as thrombolysis.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that rapid admission to hospital following a stroke is vital for ensuring patients have timely access to treatments such as thrombolysis?

Yes. Rapid hospital admission following an acute stroke is critical because the efficacy of reperfusion treatments like thrombolysis diminishes rapidly over time.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently emphasize the time-sensitive nature of acute stroke treatments, particularly intravenous thrombolysis, where treatment delay significantly reduces clinical benefits and increases relative risks. Multiple studies and reviews support the foundational 'time is brain' paradigm.

Evidence for · 2
2026
The review details how the benefit of intravenous thrombolysis decays steeply with time, making rapid intervention essential for maximizing good patient outcomes.
Get citation
F, C., N, C., S, A., & DK, A. (2026). Door-to-Needle Optimization in Acute Ischemic Stroke: A Review of Rapid Emergency Department Interventions.. doi.org. https://doi.org/10.26502/fccm.92920503

See more details
More for · 1
2026
Data from a massive national stroke registry confirms a time-dependent beneficial effect of thrombolysis that declines rapidly as post-onset hours pass.
Get citation
K, P., M, A., A, L., P, M., R, E., M, K., J, S., E, K., J, D., L, F., L, A., A, B., & M, J. (2026). A machine learning study of the effect of thrombolysis on outcome at discharge in the UK stroke registry: how does benefit compare with clinical trials?. doi.org. https://doi.org/10.1093/esj/aakag078

What does the evidence say?

The retrieved papers consistently emphasize the time-sensitive nature of acute stroke treatments, particularly intravenous thrombolysis, where treatment delay significantly reduces clinical benefits and increases relative risks. Multiple studies and reviews support the foundational 'time is brain' paradigm.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work